We are delighted to announce that Ian Ormiston has been appointed as Maxillofacial Sub-editor for the magazine. Ian is Consultant Maxillofacial Cleft Surgeon based at Leicester Royal Infirmary, England. He has a background in dentistry, medicine and surgery. His interests...
This paper assesses patients presenting with oral and maxillofacial trauma over a 13-year period spanning January 2003 to December 2015. During this period of time, in March 2008, trading hours and conditions of service were restricted within the Newcastle central...
Although the management of medical relation osteonecrosis of the jaw is usually provided by colleagues in maxillofacial surgery, it is essential for ENT surgeons to effectively diagnose the various presentations of this condition. Affected bone that is exposed and necrotic...
The authors begin by emphasising the importance of complete medical records in maxillo-facial trauma by pointing to the fact that the records not only provide the necessary clinical information but also provide legal protection of both the patient and the...
There is some evidence that severe or complex midfacial or orbital fractures have declined over the last decade. Interestingly there is also evidence of an increase in road traffic accidents but a decrease in facial injuries. This is possibly attributed...
This article provides a thorough summary of the current techniques available in head and neck reconstruction. It details the challenge of restoration of form and function posed by the shape of the craniofacial skeleton and soft tissue. The introduction on...
Orthognathic surgery is developing as a viable and long-lasting treatment option for obstructive sleep apnoea syndrome (OSAS). There have been a growing number of publications that report the benefit of using conventional orthognathic techniques for OSAS. In the present retrospective...
This CPD accredited virtual event taking place over the course of 2days, aims to build on the successes of the last eleven years and will explore the treatment options available for recurrent cancer in the head and neck setting.